A Look Into The Future Of Bioprocessing

By Dr. Svea Grieb, Kai Touw and Dan Kopec

The internet of things and robotics are already the working standard in fast-adapting industries. These technologies are now also being implemented in the biopharma industry, which is more conservative due to strong regulations and intrinsically complex processes. How is this change going to proceed and how does it change the industry? Does it provide a bigger benefit than its risk? We asked three experts for process analytical technologies, automation, and data analytics from Sartorius about their view on the future of bioprocessing.